NORMAL SITUATION

DR. IVETTE ESSERS REUMATOLOGE

Export PDF

Company — Normal situation.

Financial year 2025 · Closed on 13/11/2025

Net result4,9 k €-19,9 %over 1 year
Gross margin-1,6 k €-105,2 %over 1 year
Equity0 €-100,0 %over 1 year
Workforce0,0 ETP

Identity

Source · BCE/KBO

DR. IVETTE ESSERS REUMATOLOGE is a company registered in Belgium.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0786.684.351
Legal form
Private limited company
Contributed capital
0,00 €
Latest accounts
13/11/2025
Average workforce
0,0 ETP
Signals
Profitable

Financials

Source · NBB, 4 filings

Trend over 4 financial years

2025202420232022
Income statement
Gross margin-1,6 k €31,5 k €67,2 k €23,2 k €
EBITDA-1,8 k €18,6 k €66,9 k €23 k €
Operating result6,7 k €10,1 k €59,9 k €19,9 k €
Net result4,9 k €6,1 k €45,8 k €13,9 k €
Balance sheet
Equity0 €68,9 k €62,8 k €16,9 k €
Total assets77,1 k €104,2 k €99 k €51,4 k €
Cash36 k €85,2 k €56,9 k €12,5 k €
Debts77,1 k €26,8 k €36,3 k €34,4 k €
Other
Workforce0,0 ETP0,0 ETP––

Board of directors

Source · NBB, accounts to 31/12/2024

1 active

Active mandates

Ivette Essers

Director · since 31 mai 2022

Active

Full financial information

Source · NBB
2025202420232022
Type of accountAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202331/05/2022
Closing of the financial year13/11/202531/12/202431/12/202331/12/2022
Length of the financial year11 months12 months12 months8 months
Filing date19/12/202529/07/202511/07/202407/07/2023
General meeting13/11/202520/06/202521/06/202416/06/2023
Currency of the financial yearEUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 4 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model13/11/202513/11/202519/12/2025DutchPDF
Abridged model31/12/202420/06/202529/07/2025DutchPDF
Abridged model31/12/202321/06/202411/07/2024DutchPDF
Abridged model31/12/202216/06/202307/07/2023DutchPDF

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2024

1 active

Active mandates

Ivette Essers

Director · since 31 mai 2022

Active

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Dissolution08/12/2025
    RUBRIEK EINDE (STOPZETTING, INTREKKING STOPZETTING, NIETIGHEID, GER. AK., GERECHTELIJKE REORGANISATIE, ENZ...
    PDF
  • Other02/06/2022
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 20254,9 k €↓
  2. 2025
    Name changeDr. Ivette Essers Reumatologe in vereffening
  3. 2024
    Annual accounts 20246,1 k €↓
  4. 2023
    Annual accounts 202345,8 k €↑
  5. 2022
    Annual accounts 202213,9 k €
  6. 2022
    Name changeDr. Ivette Essers Reumatologe